Compared to traditional cell-based assay monolayers, three-dimensional (3-D) models more closely mimic native tissues. 3-D tissue models provide a means for systematic, repetitive and quantitative investigation of drugs, serving as platforms for screening of drugs as well as pharmacokinetic and pharmacodynamic analysis of drugs. That said, creating the more biologically relevant third dimension of tissue models requires a multidisciplinary approach and multidisciplinary expertise.
Taking place October 28-29 in Cambridge, MA, Cambridge Healthtech Institute’s Second Annual Engineering Functional 3-D Tissue Models meeting weaves together engineers, biologists and pharmacologists. As with any model, each specialty provides insights into the complete system advancing drug discovery and development, from designing the bioreactors, to engineering the 3-D models, to studying healthy versus diseased states, to utilizing drug screening assays.
Event BrochureVenue:
Le Meridien Cambridge-MIT
Location: 20 Sidney St, Cambridge, MA
Country: United Kingdom
Organiser Contact Details:
Cambridge Healthtech InstituteT:
781-972-5400reg@healthtech.com